epocrates logo
epocrates logo
epocrates logo
  • 0

Interaction Check

epocrates logo

Sign in to access our clinical decision support tools

Sign in Create Account

Selected Drugs Clear All

  • remove Brixadi
    buprenorphine
  • remove Orlynvah
    sulopenem etzadroxil/ probenecid
  • remove Venofer
    iron sucrose
  • remove Viberzi
    eluxadoline

multicheck MultiCheck Results - 2 Interactions

Smiley face Smiley face

Avoid/Use Alternative

Smiley face Smiley face Brixadi (buprenorphine) + Viberzi (eluxadoline)

Avoid/Use Alternative


buprenorphine + eluxadoline

avoid combo: combo may incr. risk of severe constipation, paralytic ileus (additive effects)

Monitor/Modify Tx

Smiley face Smiley face Brixadi (buprenorphine) + Venofer (iron sucrose)

Monitor/Modify Tx


buprenorphine + iron sucrose

monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

Additional Considerations

Smiley face Smiley face sulopenem in Orlynvah

sulopenem etzadroxil (prodrug) converted to sulopenem

Smiley face Smiley face buprenorphine in Brixadi

consider prescribing an opioid overdose reversal agent, especially with concomitant CNS depressant use

Help
FDA Reporting Form
 
Download Epocrates from the App Store Download Epocrates from the Play Store
About Us Features Business Solutions Help & Feedback
© 2026 epocrates, Inc.    Terms of Use Privacy Policy Editorial Policy Do Not Sell or Share My Information